Post-pandemic Era-Global Anti-Infective Drug Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type

Report ID: 246396 | Published Date: Jan 2025 | No. of Page: 95 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents

Global Anti-Infective Drug Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
    1.1 Product Details and Introduction
      1.1.1 Antibiotics -Product Introduction and Major Manufacturers
      1.1.2 Antivirals -Product Introduction and Major Manufacturers
      1.1.3 Antifungals -Product Introduction and Major Manufacturers
      1.1.4 Others -Product Introduction and Major Manufacturers
    1.2 Market Snapshot
      1.2.1 Major Companies Overview
      1.2.2 Market Concentration
      1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market
    2.1 Regional Market Share in Terms of Production (2019-2026)
    2.2 Regional Market Share in Terms of Revenue (2019-2026)
    2.3 Regional Market Share in Terms of Consumption (2019-2026)
3 Global Anti-Infective Drug Market Assessment by Type
    3.1 Global Anti-Infective Drug Production by Type (2015-2026)
    3.2 Global Anti-Infective Drug Revenue by Type (2015-2026)
    3.3 North America Anti-Infective Drug Production and Revenue by Type (2015-2026)
    3.4 Asia Anti-Infective Drug Production and Revenue by Type (2015-2026)
    3.5 Europe Anti-Infective Drug Production and Revenue by Type (2015-2026)
    3.6 Middle East & Africa Anti-Infective Drug Production and Revenue by Type (2015-2026)
    3.7 South America Anti-Infective Drug Production and Revenue by Type (2015-2026)

4 Global Anti-Infective Drug Market Assessment by Application
    4.1 Historical & Forecast Global Anti-Infective Drug Consumption, Different Application Field (2015-2026)
    4.2 Historical & Forecast North America Anti-Infective Drug Consumption, Different Application Field (2015-2026)
    4.3 Historical & Forecast Asia Anti-Infective Drug Consumption, Different Application Field (2015-2026)
    4.4 Historical & Forecast Europe Anti-Infective Drug Consumption, Different Application Field (2015-2026)
    4.5 Historical & Forecast Middle East & Africa Anti-Infective Drug Consumption, Different Application Field (2015-2026)
    4.6 Historical & Forecast South America Anti-Infective Drug Consumption, Different Application Field (2015-2026)

5 North America
    5.1 US Anti-Infective Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    5.2 Canada Anti-Infective Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    5.3 Mexico Anti-Infective Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
6 Asia
    6.1 China Anti-Infective Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    6.2 Japan Anti-Infective Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    6.3 India Anti-Infective Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    6.4 Korea Anti-Infective Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    6.5 Southeat Asia Anti-Infective Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
7 Europe
    7.1 Germany Anti-Infective Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    7.2 UK Anti-Infective Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    7.3 France Anti-Infective Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    7.4 Russia Anti-Infective Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    7.5 Italy Anti-Infective Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
8 Middle East and Africa
    8.1 Saudi Anti-Infective Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    8.2 UAE Anti-Infective Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    8.3 Egypt Anti-Infective Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    8.4 Nigeria Anti-Infective Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    8.5 South Africa Anti-Infective Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
9 South America
    9.1 Brazil Anti-Infective Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    9.2 Argentina Anti-Infective Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    9.3 Colombia Anti-Infective Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
10 Global Anti-Infective Drug Average Price Trend
    10.1 Market Price for Each Type of Anti-Infective Drug in North America (2015-2026)
    10.2 Market Price for Each Type of Anti-Infective Drug in Asia (2015-2026)
    10.3 Market Price for Each Type of Anti-Infective Drug in Europe (2015-2026)
    10.4 Market Price for Each Type of Anti-Infective Drug in Middle East & Africa (2015-2026)
    10.5 Market Price for Each Type of Anti-Infective Drug in South America (2015-2026)

11 Value Chain (Impact of COVID-19)
    11.1 Anti-Infective Drug Value Chain Analysis
      11.1.1 Upstream
      11.1.2 Downstream
    11.2 COVID-19 Impact on Anti-Infective Drug Industry
      11.2.1 Industrial Policy Issued Under the Epidemic Situation
    11.3 Cost-Under the Epidemic Situation
      11.3.1 Cost of Raw Material
    11.4 Channel Analysis
      11.4.1 Distribution Channel-Under the Epidemic Situation
      11.4.2 Distributors

12 Anti-Infective Drug Competitive Analysis
     12.1 Gilead Sciences
        12.1.1 Gilead Sciences Company Profiles
        12.1.2 Gilead Sciences Product Introduction
        12.1.3 Gilead Sciences Anti-Infective Drug Production, Revenue (2015-2020)
        12.1.4 SWOT Analysis
     12.2 GlaxoSmithKline
        12.2.1 GlaxoSmithKline Company Profiles
        12.2.2 GlaxoSmithKline Product Introduction
        12.2.3 GlaxoSmithKline Anti-Infective Drug Production, Revenue (2015-2020)
        12.2.4 SWOT Analysis
     12.3 Merck
        12.3.1 Merck Company Profiles
        12.3.2 Merck Product Introduction
        12.3.3 Merck Anti-Infective Drug Production, Revenue (2015-2020)
        12.3.4 SWOT Analysis
     12.4 Teva Pharmaceutical Industries
        12.4.1 Teva Pharmaceutical Industries Company Profiles
        12.4.2 Teva Pharmaceutical Industries Product Introduction
        12.4.3 Teva Pharmaceutical Industries Anti-Infective Drug Production, Revenue (2015-2020)
        12.4.4 SWOT Analysis
     12.5 Bristol-Myers Squibb
        12.5.1 Johnson & Johnson Company Profiles
        12.5.2 Johnson & Johnson Product Introduction
        12.5.3 Johnson & Johnson Anti-Infective Drug Production, Revenue (2015-2020)
        12.5.4 SWOT Analysis
     12.6 Boehringer Ingelheim
        12.6.1 Boehringer Ingelheim Company Profiles
        12.6.2 Boehringer Ingelheim Product Introduction
        12.6.3 Boehringer Ingelheim Anti-Infective Drug Production, Revenue (2015-2020)
        12.6.4 SWOT Analysis
     12.7 Pfizer
        12.7.1 Pfizer Company Profiles
        12.7.2 Pfizer Product Introduction
        12.7.3 Pfizer Anti-Infective Drug Production, Revenue (2015-2020)
        12.7.4 SWOT Analysis
     12.8 Mylan N.V.
        12.8.1 Mylan N.V. Company Profiles
        12.8.2 Mylan N.V. Product Introduction
        12.8.3 Mylan N.V. Anti-Infective Drug Production, Revenue (2015-2020)
        12.8.4 SWOT Analysis
     12.9 Bristol-Myers Squibb
        12.9.1 Bristol-Myers Squibb Company Profiles
        12.9.2 Bristol-Myers Squibb Product Introduction
        12.9.3 Bristol-Myers Squibb Anti-Infective Drug Production, Revenue (2015-2020)
        12.9.4 SWOT Analysis
     12.10 F. Hoffmann-La Roche
        12.10.1 F. Hoffmann-La Roche Company Profiles
        12.10.2 F. Hoffmann-La Roche Product Introduction
        12.10.3 F. Hoffmann-La Roche Anti-Infective Drug Production, Revenue (2015-2020)
        12.10.4 SWOT Analysis
     12.11 Shanghai Pharmaceuticals
13 Conclusion



List of Tables and Figures

    Figure Product Introduction
    Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
    Figure Global Anti-Infective Drug Production Market Share of Top 5 Players
    Table CAGR of Major Market (2021-2026)
    Table CAGR in Terms of Production of Each Type (2015-2026)
    Table Regional Market Share in Terms of Production (2019-2026)
    Figure Regional Market Share in Terms of Production (2019 - 2020)
    Table Regional Market Share in Terms of Revenue (2019-2026)
    Figure Regional Market Share in Terms of Revenue (2019 - 2020)
    Figure Regional Market Share in Terms of Consumption (2019 - 2020)
    Figure Regional Market Share in Terms of Consumption (2019 - 2020)
    Table Global Anti-Infective Drug Production (K Unit) by Type (2015-2026)
    Figure Global Anti-Infective Drug Production (K Unit) and Growth Rate (2015-2026)
    Figure Global Anti-Infective Drug Production Market Share (%) by Type (2019 -2020)
    Table Global Anti-Infective Drug Revenue (Million USD) by Type (2015-2026)
    Figure Global Anti-Infective Drug Revenue (Million USD) and Growth Rate (2015-2026)
    Figure Global Anti-Infective Drug Revenue Market Share (%) by Type (2019-2020)
    Figure North America Anti-Infective Drug Production (K Unit) by Type (2015-2026)
    Figure North America Anti-Infective Drug Production (K Unit) and Growth Rate (2015-2026)
    Figure North America Anti-Infective Drug Revenue (Million USD) by Type (2015-2026)
    Figure North America Anti-Infective Drug Revenue (Million USD) and Growth Rate (2015-2026)
    Figure Asia Anti-Infective Drug Production (K Unit) by Type (2015-2026)
    Figure Asia Anti-Infective Drug Production (K Unit) and Growth Rate (2015-2026)
    Figure Asia Anti-Infective Drug Revenue (Million USD) by Type (2015-2026)
    Figure Asia Anti-Infective Drug Revenue (Million USD) and Growth Rate (2015-2026)
    Figure Europe Anti-Infective Drug Production (K Unit) by Type (2015-2026)
    Figure Europe Anti-Infective Drug Production (K Unit) and Growth Rate (2015-2026)
    Figure Europe Anti-Infective Drug Revenue (Million USD) by Type (2015-2026)
    Figure Europe Anti-Infective Drug Revenue (Million USD) and Growth Rate (2015-2026)
    Figure Middle East & Africa Anti-Infective Drug Production (K Unit) by Type (2015-2026)
    Figure Middle East & Africa Anti-Infective Drug Production (K Unit) and Growth Rate (2015-2026)
    Figure Middle East & Africa Anti-Infective Drug Revenue (Million USD) by Type (2015-2026)
    Figure Middle East & Africa Anti-Infective Drug Revenue (Million USD) and Growth Rate (2015-2026)
    Figure South America Anti-Infective Drug Production (K Unit) by Type (2015-2026)
    Figure South America Anti-Infective Drug Production (K Unit) and Growth Rate (2015-2026)
    Figure South America Anti-Infective Drug Revenue (Million USD) by Type (2015-2026)
    Figure South America Anti-Infective Drug Revenue (Million USD) and Growth Rate (2015-2026)
    Table Historical & Forecast Anti-Infective Drug Different Application Field Consumption (K Unit)
    Figure Consumption (K Unit) and Growth Rate (2015-2026)
    Figure Different Application Field Consumption Market Share (%) (2019-2020)
    Table Historical & Forecast Anti-Infective Drug Different Application Field Consumption (K Unit)
    Figure North America Anti-Infective Drug Consumption (K Unit) and Growth Rate (2015-2026)
    Figure North America Anti-Infective Drug Consumption Market Share (%) by Application (2015-2026)
    Table Historical & Forecast Anti-Infective Drug Different Application Field Consumption (K Unit)
    Figure Asia Anti-Infective Drug Consumption (K Unit) and Growth Rate (2015-2026)
    Figure Asia Anti-Infective Drug Consumption Market Share (%) by Application (2015-2026)
    Table Historical & Forecast Anti-Infective Drug Different Application Field Consumption (K Unit)
    Figure Europe Anti-Infective Drug Consumption (K Unit) and Growth Rate (2015-2026)
    Figure Europe Anti-Infective Drug Consumption Market Share (%) by Application (2015-2026)
    Table Historical & Forecast Anti-Infective Drug Different Application Field Consumption (K Unit)
    Figure Middle East & Africa Anti-Infective Drug Consumption (K Unit) and Growth Rate (2015-2026)
    Figure Middle East & Africa Anti-Infective Drug Consumption Market Share (%) by Application (2015-2026)
    Table Historical & Forecast Anti-Infective Drug Different Application Field Consumption (K Unit)
    Figure South America Anti-Infective Drug Consumption (K Unit) and Growth Rate (2015-2026)
    Figure South America Anti-Infective Drug Consumption Market Share (%) by Application (2015-2026)
    Table Historical & Forecast Anti-Infective Drug Different Application Field Consumption (K Unit)
    Table US Anti-Infective Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Canada Anti-Infective Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Mexico Anti-Infective Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table China Anti-Infective Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Japan Anti-Infective Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table India Anti-Infective Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Korea Anti-Infective Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Southeast Asia Anti-Infective Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Germany Anti-Infective Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table UK Anti-Infective Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table France Anti-Infective Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Russia Anti-Infective Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Italy Anti-Infective Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Saudi Anti-Infective Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table UAE Anti-Infective Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Egypt Anti-Infective Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Nigeria Anti-Infective Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table South Africa Anti-Infective Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Brazil Anti-Infective Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Argentina Anti-Infective Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Colombia Anti-Infective Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Market Price (USD/Unit) for Each Type of Anti-Infective Drug in China
    Table Market Price (USD/Unit) for Each Type of Anti-Infective Drug in EU
    Table Market Price (USD/Unit) for Each Type of Anti-Infective Drug in USA
    Table Market Price (USD/Unit) for Each Type of Anti-Infective Drug in Japan
    Table Market Price (USD/Unit) for Each Type of Anti-Infective Drug in India
    Table Market Price (USD/Unit) for Each Type of Anti-Infective Drug in Southeast Asia
    Table Market Price (USD/Unit) for Each Type of Anti-Infective Drug in South America
    Figure Value Chain Structure of Anti-Infective Drug
    Table Value Chain
    Table Key Suppliers of Raw Material/Components
    Table Key Downstream Customer in Each Application Field
    Table Industry News List of Anti-Infective Drug
    Figure Cost Structure of Anti-Infective Drug in 2020
    Table Distributors/Traders List
    Table Gilead Sciences Profiles
    Table Gilead Sciences Anti-Infective Drug Product Introduction
    Figure Gilead Sciences Anti-Infective Drug Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Gilead Sciences SWOT Analysis
    Table GlaxoSmithKline Profiles
    Table GlaxoSmithKline Anti-Infective Drug Product Introduction
    Figure GlaxoSmithKline Anti-Infective Drug Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure GlaxoSmithKline SWOT Analysis
    Table Merck Profiles
    Table Merck Anti-Infective Drug Product Introduction
    Figure Merck Anti-Infective Drug Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Merck SWOT Analysis
    Table Teva Pharmaceutical Industries Profiles
    Table Teva Pharmaceutical Industries Anti-Infective Drug Product Introduction
    Figure Teva Pharmaceutical Industries Anti-Infective Drug Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Teva Pharmaceutical Industries SWOT Analysis
    Table Johnson & Johnson Profiles
    Table Johnson & Johnson Anti-Infective Drug Product Introduction
    Figure Johnson & Johnson Pharma & Healthcare Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Johnson & Johnson SWOT Analysis
    Table Boehringer Ingelheim Profiles
    Table Boehringer Ingelheim Anti-Infective Drug Product Introduction
    Figure Boehringer Ingelheim Anti-Infective Drug Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Boehringer Ingelheim SWOT Analysis
    Table Pfizer Profiles
    Table Pfizer Anti-Infective Drug Product Introduction
    Figure Pfizer Anti-Infective Drug Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Pfizer SWOT Analysis
    Table Mylan N.V. Profiles
    Table Mylan N.V. Anti-Infective Drug Product Introduction
    Figure Mylan N.V. Anti-Infective Drug Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Mylan N.V. SWOT Analysis
    Table Bristol-Myers Squibb Profiles
    Table Bristol-Myers Squibb Anti-Infective Drug Product Introduction
    Figure Bristol-Myers Squibb Anti-Infective Drug Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Bristol-Myers Squibb SWOT Analysis
    Table F. Hoffmann-La Roche Profiles
    Table F. Hoffmann-La Roche Anti-Infective Drug Product Introduction
    Figure F. Hoffmann-La Roche Anti-Infective Drug Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure F. Hoffmann-La Roche SWOT Analysis
    Table Shanghai Pharmaceuticals Profiles
    Table Shanghai Pharmaceuticals Anti-Infective Drug Product Introduction
    Figure Shanghai Pharmaceuticals Anti-Infective Drug Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Post-pandemic Era-Global Anti-Infective Drug Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Post-pandemic Era-Global Anti-Infective Drug Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Post-pandemic Era-Global Anti-Infective Drug Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports